中商官网
研究报告
华润医药（HK3320）
| 科目\年度 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 |
原始货币 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 审计意见 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 报表核心指标 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 税后利润 |
840324.30 | 777500.30 | 665792.90 | 664740.60 | 532364.10 | 509780.30 | 757232.40 | 686686.60 | 596808.90 | 608223.40 | 549187.10 | 545462.70 |
| 营业收入 |
25767320.00 | 24470390.00 | 21818300.00 | 23680620.00 | 20042300.00 | 20445390.00 | 18968910.00 | 17253220.00 | 15670520.00 | 14656810.00 | 13574920.00 | 11695070.00 |
| 销售成本 |
21698440.00 | 20636640.00 | 18456390.00 | 20142590.00 | 16812920.00 | 17043620.00 | 15475870.00 | 14425610.00 | 13259610.00 | 12336920.00 | 11425920.00 | 9680161.00 |
| 税前利润 |
1092992.00 | 988022.70 | 836108.10 | 840843.20 | 707550.80 | 663956.80 | 918247.70 | 858234.80 | 804266.50 | 805029.40 | 692277.30 | 691291.30 |
| 归属于母公司股东利润 |
335085.70 | 385424.70 | 350027.00 | 376888.90 | 329712.60 | 328641.90 | 397760.30 | 348303.60 | 282141.00 | 285007.60 | 264594.00 | 263951.70 |
| 营业收入 |
25767320.00 | 24470390.00 | 21818300.00 | 23680620.00 | 20042300.00 | 20445390.00 | 18968910.00 | 17253220.00 | 15670520.00 | 14656810.00 | 13574920.00 | 11695070.00 |
| 其中：营业额 |
25767320.00 | 24470390.00 | 21818300.00 | 23680620.00 | 20042300.00 | 20445390.00 | 18968910.00 | 17253220.00 | 15670520.00 | 14656810.00 | 13574920.00 | 11695070.00 |
| 销售成本 |
21698440.00 | 20636640.00 | 18456390.00 | 20142590.00 | 16812920.00 | 17043620.00 | 15475870.00 | 14425610.00 | 13259610.00 | 12336920.00 | 11425920.00 | 9680161.00 |
| 毛利 |
4068887.00 | 3833749.00 | 3361905.00 | 3538029.00 | 3229386.00 | 3401769.00 | 3493038.00 | 2827615.00 | 2410910.00 | 2319886.00 | 2149002.00 | 2014908.00 |
| 加：其他收入 |
16990.80 | 23113.60 | 11978.00 | 22321.80 | -1117.20 | 122503.10 | 159565.30 | 132723.50 | 132023.50 | 209393.20 | 113591.60 | 91956.20 |
| 减：销售费用 |
1980990.00 | 1890990.00 | 1639524.00 | 1753070.00 | 1602945.00 | 1918852.00 | 1834088.00 | 1386878.00 | 1094748.00 | 1011155.00 | 880015.30 | 842311.40 |
| 管理费用 |
672740.40 | 632816.60 | 557862.30 | 623625.90 | 556449.50 | 520376.80 | 479342.90 | 424707.90 | 395305.00 | 384489.20 | 424677.30 | 367350.50 |
| 财务费用 |
160077.90 | 179862.60 | 173228.90 | 201535.20 | 247750.80 | 307622.00 | 293427.70 | 223094.90 | 179606.20 | 205046.20 | 213459.90 | 177073.40 |
| 其他费用 |
214782.10 | 204416.20 | 187836.20 | 174527.80 | 134714.40 | 126062.60 | 135185.00 | 87278.90 | 95650.20 | 136315.70 | 88604.20 | 44551.80 |
| 加：投资物业公允价值变动 |
-1096.00 | -2464.90 | -12558.20 | 1892.00 | 455.90 | -1443.30 | -- | 5777.20 | 21826.00 | 6933.40 | 29976.30 | 10808.40 |
| 经营溢利 |
1056191.00 | 946312.10 | 802874.00 | 809483.50 | 686865.60 | 649915.10 | 910559.60 | 844155.30 | 799450.10 | 799207.10 | 685813.30 | 686385.90 |
| 加：应占联营公司业绩 |
-- | -- | -- | -- | -- | -- | -- | -- | 4816.40 | 5822.40 | 6464.00 | 5491.70 |
| 应占共同控制实体业绩 |
-- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -586.30 |
| 税前利润特殊科目 |
36801.40 | 41710.60 | 33234.10 | 31359.70 | 20685.20 | 14041.70 | 7688.10 | 14079.50 | -- | -- | -- | -- |
| 税前利润 |
1092992.00 | 988022.70 | 836108.10 | 840843.20 | 707550.80 | 663956.80 | 918247.70 | 858234.80 | 804266.50 | 805029.40 | 692277.30 | 691291.30 |
| 减：所得税费用 |
252667.90 | 210522.40 | 170315.20 | 176102.60 | 175186.70 | 154176.50 | 161015.30 | 171548.20 | 207457.60 | 196806.10 | 143090.20 | 145828.60 |
| 税后利润 |
840324.30 | 777500.30 | 665792.90 | 664740.60 | 532364.10 | 509780.30 | 757232.40 | 686686.60 | 596808.90 | 608223.40 | 549187.10 | 545462.70 |
| 归属于母公司股东利润 |
335085.70 | 385424.70 | 350027.00 | 376888.90 | 329712.60 | 328641.90 | 397760.30 | 348303.60 | 282141.00 | 285007.60 | 264594.00 | 263951.70 |
| 归属于非控制股股东利润 |
505238.60 | 392075.60 | 315765.90 | 287851.70 | 202651.50 | 181138.40 | 359472.10 | 338383.00 | 314667.90 | 323215.80 | 284593.10 | 281511.00 |
| 基本每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 稀释每股收益 |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 其他综合收益 |
-4867.10 | -5669.70 | -74402.30 | 249912.30 | 538855.10 | -178964.50 | -381794.40 | 429795.20 | -272236.70 | -228682.30 | -17410.00 | 84783.30 |
| 综合收益总额 |
835457.20 | 771830.60 | 591390.60 | 914652.90 | 1071219.00 | 330815.80 | 375438.00 | 1116482.00 | 324572.20 | 379541.10 | 531777.10 | 630246.00 |
| 归属于母公司股东综合收益总额 |
331913.20 | 379520.30 | 275838.10 | 517846.90 | 647414.40 | 244740.60 | 150462.70 | 610160.00 | 153201.00 | 167414.60 | 252322.70 | 299901.70 |
| 归属于非控制股股东综合收益总额 |
503544.00 | 392310.30 | 315552.50 | 396806.00 | 423804.70 | 86075.20 | 224975.30 | 506321.80 | 171371.20 | 212126.50 | 279454.40 | 330344.30 |